We are live on ! Find out more
BSTC

BioSpecifics Technologies Corp.
BSTC

Delisted

BSTC was delisted on the 1st of December, 2020.

Back to rankings

117 hedge funds and large institutions have $264M invested in BioSpecifics Technologies Corp. in 2019 Q1 according to their latest regulatory filings, with 16 funds opening new positions, 36 increasing their positions, 43 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

167% more first-time investments, than exits

New positions opened: 16 | Existing positions closed: 6

9% more funds holding

Funds holding: 107 → 117 (+10)

1% more capital invested

Capital invested by funds: $263M → $264M (+$1.54M)

16% less repeat investments, than reductions

Existing positions increased: 36 | Existing positions reduced: 43

50% less funds holding in top 10

Funds holding in top 10: 2 → 1 (-1)

Holders
117
Holders Change
+10
Holders Change %
+9.35%
% of All Funds
2.53%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.02%
New
16
Increased
36
Reduced
43
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
RHJA
Rice Hall James & Associates
California
+$4.28M
2
Renaissance Technologies
Renaissance Technologies
New York
+$4.25M
3
MCM
Matarin Capital Management
New York
+$2.84M
4
Deutsche Bank
Deutsche Bank
Germany
+$2.55M
5
CCMG
Clark Capital Management Group
Pennsylvania
+$2.45M

Top Sellers

Rank Fund Capital Flow
1
SCM
Stonepine Capital Management
Oregon
-$13.2M
2
BlackRock
BlackRock
New York
-$7.17M
3
ECP
Elk Creek Partners
Colorado
-$2.11M
4
Goldman Sachs
Goldman Sachs
New York
-$1.96M
5
EP
Eversept Partners
New York
-$1.33M
Name Holding Trade Value Shares
Change 		Change in
Stake
CAM
26
ClariVest Asset Management
California
$2.47M -$107K -1,615 -4%
CCM
27
Cadence Capital Management
Massachusetts
$2.32M -$1.08M -16,281 -30%
CCMG
28
Clark Capital Management Group
Pennsylvania
$2.31M +$2.45M +37,084 New
First Manhattan
29
First Manhattan
New York
$2.27M -$370K -5,590 -13%
ACA
30
Apis Capital Advisors
New York
$2.24M -$265K -4,000 -10%
Man Group
31
Man Group
United Kingdom
$2.12M -$6.62K -100 -0.3%
PPA
32
Parametric Portfolio Associates
Washington
$1.78M +$878K +13,275 +87%
Invesco
33
Invesco
Georgia
$1.44M -$55.5K -839 -4%
EGI
34
EAM Global Investors
California
$1.42M – – –
California Public Employees Retirement System
35
California Public Employees Retirement System
California
$1.42M +$301K +4,551 +25%
Millennium Management
36
Millennium Management
New York
$1.2M -$112K -1,689 -8%
Russell Investments Group
37
Russell Investments Group
United Kingdom
$1.16M -$376K -5,679 -23%
TCIM
38
TIAA CREF Investment Management
New York
$1.15M -$917K -13,870 -43%
VRS
39
Virginia Retirement Systems
Virginia
$1.14M +$900K +13,600 +289%
EI
40
EAM Investors
California
$1.1M – – –
Assenagon Asset Management
41
Assenagon Asset Management
Luxembourg
$1.03M -$488K -7,379 -31%
Morgan Stanley
42
Morgan Stanley
New York
$1.02M +$421K +6,358 +64%
NA
43
Navellier & Associates
Nevada
$982K +$731K +11,055 +235%
BIM
44
Bogle Investment Management
Massachusetts
$916K +$972K +14,700 New
OAM
45
Oxford Asset Management
United Kingdom
$869K -$1.31M -19,762 -59%
BCM
46
Bridgeway Capital Management
Texas
$818K -$232K -3,500 -21%
CEP
47
Chicago Equity Partners
Illinois
$796K +$845K +12,771 New
TA
48
Teachers Advisors
New York
$772K +$79.8K +1,207 +11%
Citadel Advisors
49
Citadel Advisors
Florida
$733K +$778K +11,758 New
GCP
50
GSA Capital Partners
United Kingdom
$717K +$278K +4,200 +58%
1
2
3 4 5

BSTC Hedge Fund Activity: Q1 2019 in Review

117 of the 4,620 institutional investors tracked by Wall St. Rank reported a position in BioSpecifics Technologies Corp. (BSTC) for Q1 2019, worth a combined $264M — up 0.59% from $263M a quarter earlier.

Buyers outnumbered sellers: 16 funds opened new BSTC positions and 6 closed out — a net gain of 10 holders — while 36 added to existing stakes and 43 trimmed.

The largest buyer was Rice Hall James & Associates, adding an estimated $4.28M. The largest seller was Stonepine Capital Management, exiting entirely with an estimated $13.2M sold.

  • 117 institutional investors held BioSpecifics Technologies Corp. (BSTC) as of Q1 2019, up from 107 in Q4 2018.
  • Funds reported $264M of BioSpecifics Technologies Corp. stock for Q1 2019, up 0.59% quarter-over-quarter.
  • 16 funds opened new BioSpecifics Technologies Corp. positions in Q1 2019 and 6 closed out, a net change of +10 holders.
  • The largest BioSpecifics Technologies Corp. buyer in Q1 2019 was Rice Hall James & Associates, an estimated $4.28M added.
  • The largest BioSpecifics Technologies Corp. seller in Q1 2019 was Stonepine Capital Management, an estimated $13.2M sold.

Based on aggregated 13F filings for Q1 2019.